Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 648
Last updated 2019-08-05
Summary
The purpose of this study is to describe most characteristic association of signs and symptoms present at the time of acromegaly diagnosis.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- France
Study Locations
More Related Trials
-
Diet in the Management of Acromegaly
NCT05401084 ·Status: RECRUITING ·Phase: NA
-
Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
NCT02152124 ·Status: COMPLETED
-
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
NCT01471405 ·Status: COMPLETED
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
NCT02698384 ·Status: TERMINATED
-
Growth Hormone and Heart Failure
NCT00190359 ·Status: TERMINATED
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED
-
Surgical Versus Medical Treatment of Acromegaly
NCT01000090 ·Status: COMPLETED
-
Epidemiology of Acromegaly in Denmark 1991-2010
NCT01752621 ·Status: UNKNOWN
-
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
NCT02115906 ·Status: UNKNOWN
-
A Prospective Study of Outcome After Therapy for Acromegaly
NCT01809808 ·Status: COMPLETED
-
Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
NCT04003519 ·Status: WITHDRAWN
-
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076 ·Status: COMPLETED ·Phase: NA
-
Muscle in Acromegaly and Cushing's Syndrome
NCT03673761 ·Status: UNKNOWN
-
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005100 ·Status: UNKNOWN
-
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
NCT02231593 ·Status: COMPLETED
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
NCT00210457 ·Status: COMPLETED ·Phase: PHASE3
-
IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
NCT02084095 ·Status: COMPLETED
-
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
NCT06344650 ·Status: RECRUITING
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Acute Application of Pegvisomant and Octreotide in Acromegaly
NCT00595140 ·Status: COMPLETED ·Phase: PHASE4
-
Late Effects of Radiosurgery on Acromegaly Study
NCT02296216 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
NCT00447499 ·Status: COMPLETED ·Phase: PHASE3